Form 4: CVS Health Executive Prem S. Shah Reports Significant Stock Option Grant
SEC Form 4 Filing
CVS Health EVP and Group President Prem S. Shah reports a large grant of premium stock options, alongside existing holdings of common stock and other derivative securities.
Summary
- Prem S. Shah, an EVP and Group President at CVS Health, filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing includes a significant grant of 746,268 premium stock options with an exercise price of $71.82, exercisable starting November 30, 2025.
- Shah also holds various other stock options with different exercise prices and vesting schedules, as well as common stock, restricted stock, ESOP shares, and deferred stock units.
- The report also details phantom stock credits under a non-qualified deferred compensation plan, payable in cash at a future date elected by Shah.
Sentiment
Score: 7
Explanation: The document is a routine filing, but the large stock option grant suggests a positive outlook for the company's future performance and aligns executive interests with shareholders.
Positives
- The grant of a large number of premium stock options to a key executive suggests confidence in the company's future performance.
- The vesting schedule of the premium stock options incentivizes long-term commitment from the executive.
- The executive's diverse holdings of common stock, restricted stock, and stock options align his interests with those of shareholders.
Risks
- The value of the stock options is dependent on the future performance of CVS Health's stock price.
- The executive's decisions could be influenced by the potential value of his stock options.
Future Outlook
The document does not contain any explicit forward-looking statements, but the stock option grants suggest an expectation of future growth and value creation.
Industry Context
This filing is a routine disclosure of executive compensation and stock ownership, common in the healthcare industry. It reflects the practice of using stock options to align executive interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard form of executive compensation in large publicly traded companies like CVS Health.
- The vesting schedules and exercise prices are typical for such grants, designed to incentivize long-term performance.
- Other large healthcare companies such as UnitedHealth Group (UNH) and Cigna (CI) also use similar stock-based compensation plans for their executives.
Stakeholder Impact
- The stock option grant could positively impact shareholder value if the company performs well.
- The executive's increased stake in the company aligns his interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2019 | Date when some stock options became exercisable. |
| 04/01/2020 | Date when some stock options became exercisable. |
| 04/01/2021 | Date when some stock options became exercisable. |
| 08/31/2021 | Date when some stock options became exercisable. |
| 04/01/2022 | Date when some stock options became exercisable. |
| 04/01/2023 | Date when some stock options became exercisable. |
| 04/01/2024 | Date when some stock options became exercisable. |
| 11/30/2024 | Date of the premium stock option grant. |
| 04/01/2025 | Date when some stock options become exercisable. |
| 11/30/2025 | Date when the premium stock options become exercisable. |
Keywords
CVS Health, stock options, Form 4, executive compensation, Prem S. Shah, beneficial ownership, derivative securities, equity, phantom stock, restricted stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.